These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36796986)

  • 1. Secondary prevention with a structured semi-interactive stroke prevention package in INDIA (SPRINT INDIA): a multicentre, randomised controlled trial.
    SPRINT INDIA trial collaborators
    Lancet Glob Health; 2023 Mar; 11(3):e425-e435. PubMed ID: 36796986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary Prevention by Structured Semi-Interactive Stroke Prevention Package in India (SPRINT INDIA) study protocol.
    Kate MP; Arora D; Verma SJ; Sylaja PN; Renjith V; Sharma M; Pandian JD;
    Int J Stroke; 2020 Jan; 15(1):109-115. PubMed ID: 31852411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community health worker-based intervention for adherence to drugs and lifestyle change after acute coronary syndrome: a multicentre, open, randomised controlled trial.
    Xavier D; Gupta R; Kamath D; Sigamani A; Devereaux PJ; George N; Joshi R; Pogue J; Pais P; Yusuf S
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):244-253. PubMed ID: 26857999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A support programme for secondary prevention in patients with transient ischaemic attack and minor stroke (INSPiRE-TMS): an open-label, randomised controlled trial.
    Ahmadi M; Laumeier I; Ihl T; Steinicke M; Ferse C; Endres M; Grau A; Hastrup S; Poppert H; Palm F; Schoene M; Seifert CL; Kandil FI; Weber JE; von Weitzel-Mudersbach P; Wimmer MLJ; Algra A; Amarenco P; Greving JP; Busse O; Köhler F; Marx P; Audebert HJ
    Lancet Neurol; 2020 Jan; 19(1):49-60. PubMed ID: 31708447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary prevention by structured semi-interactive stroke prevention package in INDIA (SPRINT INDIA): Findings from the process evaluation of a randomized controlled trial.
    Verma SJ; Gulati P; Injety RJ; Arora D; Dhasan A; Singhania A; Khatter H; Sharma M; Sylaja PN; Pandian JD
    Eur Stroke J; 2023 Dec; 8(4):1053-1063. PubMed ID: 37585729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Family-led rehabilitation after stroke in India (ATTEND): a randomised controlled trial.
    ATTEND Collaborative Group
    Lancet; 2017 Aug; 390(10094):588-599. PubMed ID: 28666682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a family-based cardiovascular risk reduction intervention in individuals with a family history of premature coronary heart disease in India (PROLIFIC): an open-label, single-centre, cluster randomised controlled trial.
    Jeemon P; Harikrishnan S; Ganapathi S; Sivasankaran S; Binukumar B; Padmanabhan S; Tandon N; Prabhakaran D
    Lancet Glob Health; 2021 Oct; 9(10):e1442-e1450. PubMed ID: 34534488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of sonothrombolysis for acute ischaemic stroke: a multicentre, double-blind, phase 3, randomised controlled trial.
    Alexandrov AV; Köhrmann M; Soinne L; Tsivgoulis G; Barreto AD; Demchuk AM; Sharma VK; Mikulik R; Muir KW; Brandt G; Alleman J; Grotta JC; Levi CR; Molina CA; Saqqur M; Mavridis D; Psaltopoulou T; Vosko M; Fiebach JB; Mandava P; Kent TA; Alexandrov AW; Schellinger PD;
    Lancet Neurol; 2019 Apr; 18(4):338-347. PubMed ID: 30878103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and effectiveness of intravenous iron sucrose versus standard oral iron therapy in pregnant women with moderate-to-severe anaemia in India: a multicentre, open-label, phase 3, randomised, controlled trial.
    Neogi SB; Devasenapathy N; Singh R; Bhushan H; Shah D; Divakar H; Zodpey S; Malik S; Nanda S; Mittal P; Batra A; Chauhan MB; Yadav S; Dongre H; Saluja S; Malhotra V; Gupta A; Sangwan R; Radhika AG; Singh A; Bhaskaran S; Kotru M; Sikka M; Agarwal S; Francis P; Mwinga K; Baswal D
    Lancet Glob Health; 2019 Dec; 7(12):e1706-e1716. PubMed ID: 31708151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structured ambulatory post-stroke care program for outpatient aftercare in patients with ischaemic stroke in Germany (SANO): an open-label, cluster-randomised controlled trial.
    Schwarzbach CJ; Eichner FA; Rücker V; Hofmann AL; Keller M; Audebert HJ; von Bandemer S; Engelter ST; Geis D; Gröschel K; Haeusler KG; Hamann GF; Meisel A; Sander D; Schutzmeier M; Veltkamp R; Heuschmann PU; Grau AJ;
    Lancet Neurol; 2023 Sep; 22(9):787-799. PubMed ID: 37459876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial.
    Kelly P; Lemmens R; Weimar C; Walsh C; Purroy F; Barber M; Collins R; Cronin S; Czlonkowska A; Desfontaines P; De Pauw A; Evans NR; Fischer U; Fonseca C; Forbes J; Hill MD; Jatuzis D; Kõrv J; Kraft P; Kruuse C; Lynch C; McCabe D; Mikulik R; Murphy S; Nederkoorn P; O'Donnell M; Sandercock P; Schroeder B; Shim G; Tobin K; Williams DJ; Price C
    Lancet; 2024 Jul; 404(10448):125-133. PubMed ID: 38857611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial.
    VITATOPS Trial Study Group
    Lancet Neurol; 2010 Sep; 9(9):855-65. PubMed ID: 20688574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial.
    Toyoda K; Uchiyama S; Yamaguchi T; Easton JD; Kimura K; Hoshino H; Sakai N; Okada Y; Tanaka K; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Isobe M; Minematsu K;
    Lancet Neurol; 2019 Jun; 18(6):539-548. PubMed ID: 31122494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a community-based intervention for cardiovascular risk factor control on stroke mortality in rural Gadchiroli, India: study protocol for a cluster randomised controlled trial.
    Kalkonde Y; Deshmukh M; Nila S; Jadhao S; Bang A
    Trials; 2019 Dec; 20(1):764. PubMed ID: 31870394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial.
    Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox KM; Hennerici MG; Mattle HP; Rothwell PM; de Cordoüe A; Fratacci MD;
    Lancet; 2011 Jun; 377(9782):2013-22. PubMed ID: 21616527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial.
    Ueki K; Sasako T; Okazaki Y; Kato M; Okahata S; Katsuyama H; Haraguchi M; Morita A; Ohashi K; Hara K; Morise A; Izumi K; Ishizuka N; Ohashi Y; Noda M; Kadowaki T;
    Lancet Diabetes Endocrinol; 2017 Dec; 5(12):951-964. PubMed ID: 29079252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of medication adherence and management of risk factors for secondary prevention of stroke (MaMoRS) using a smartphone-based application.
    Babu V; Sylaja PN; Soman B; Varma RP; Ms M; Gl G; Kumar B S
    Int J Stroke; 2024 Jul; 19(6):654-664. PubMed ID: 38533606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trial.
    Mohr JP; Overbey JR; Hartmann A; Kummer RV; Al-Shahi Salman R; Kim H; van der Worp HB; Parides MK; Stefani MA; Houdart E; Libman R; Pile-Spellman J; Harkness K; Cordonnier C; Moquete E; Biondi A; Klijn CJM; Stapf C; Moskowitz AJ;
    Lancet Neurol; 2020 Jul; 19(7):573-581. PubMed ID: 32562682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Development of Structured Semi-interactive Stroke Prevention Package for Secondary Stroke Prevention.
    Kate MP; Verma SJ; Arora D; Sylaja PN; Padma MV; Bhatia R; Khurana D; Sharma A; Ojha PK; Renjith V; Kulkarni GB; Sadiq M; Jabeen S; Borah NC; Ray BK; Sharma M; Pandian JD
    Ann Indian Acad Neurol; 2020; 23(5):681-686. PubMed ID: 33623271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.